Dell Win Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Tirumalagiri, Telangana, India, established in 2019.

2019 Tirumalagiri, Telangana, India Active

Last Updated: February 04, 2026

About Dell Win Pharmaceuticals Private Limited

Dell Win Pharmaceuticals Private Limited, a active private limited company, was established on 17 September 2019 in Tirumalagiri, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100TG2019PTC135474. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sujatha Beeravalli (Director), Rami Reddy Marri (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 503, H.O 2-22-2/83,, P.No. 83, Vivekananda Nagar, Tirumalagiri, Telangana, 500072.

Company Details

CIN/LLPIN
U24100TG2019PTC135474
Registration Number
135474
Incorporation Date
17 September 2019
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.10 M as on 04-02-2026
Paid Up Capital ₹ 0.10 M as on 04-02-2026
Company Age 6 Year, 4 Months
Last Filing with ROC 31 Mar 2024
Revenue Growth **** 3197.55% (FY 2022)
Profit Growth **** 4248.82% (FY 2022)
Ebitda **** 1466.60% (FY 2022)
Net Worth 1920.13% (FY 2022)
Total Assets **** 255.84% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Dell Win Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Dell Win Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sujatha Beeravalli	Director	17 Sep 2019	Current
Rami Reddy Marri	Director	17 Sep 2019	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dell Win Pharmaceuticals.

Dell Win Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 3197.55% increase. The company also saw a substantial improvement in profitability, with a 4248.82% increase in profit. The company's net worth Soared by an impressive increase of 1920.13%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

3197.55%

*******

Revenue from Operations

*******

3197.55%

*******

Total Assets

*******

255.84%

*******

Profit or Loss

*******

4248.82%

*******

Net Worth

*******

1920.13%

*******

EBITDA

*******

1466.60%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dell Win Pharmaceuticals?

In 2021, Dell Win Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dell Win Pharmaceuticals?

Unlock and access historical data on people associated with Dell Win Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Dell Win Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dell Win Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dell Win Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Dell Win Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
30 Sep 2024
Balance Sheet

The activity Dell Win Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
31 Mar 2024
Director Appointment

Progress on Sujatha Beeravalli was appointed as a Director was appointed as a Director on 17 Sep 2019 & has been associated with this company since 6 years 4 months . was documented.
17 Sep 2019
Director Appointment

The activity Rami Reddy Marri was appointed as a Director was appointed as a Director on 17 Sep 2019 & has been associated with this company since 6 years 4 months . was completed.
17 Sep 2019
Company Incorporation

Progress on Dell Win Pharmaceuticals Private Limited was registered on 17 Sep 2019 with Roc Hyderabad & aged 6 years 4 months as per MCA records. was documented.
17 Sep 2019

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Dell Win Pharmaceuticals Private Limited?

The CIN of Dell Win Pharmaceuticals Private Limited is U24100TG2019PTC135474.

Where is Dell Win Pharmaceuticals Private Limited headquartered?

Dell Win Pharmaceuticals Private Limited is headquartered at Flat No. 503, H.O 2-22-2/83,, P.No. 83, Vivekananda Nagar, Tirumalagiri, Telangana, 500072.

When was Dell Win Pharmaceuticals Private Limited incorporated?

Dell Win Pharmaceuticals Private Limited was incorporated on 17 September 2019.

Who are the current directors of Dell Win Pharmaceuticals Private Limited?

The current directors of Dell Win Pharmaceuticals Private Limited are

What is the primary industry of Dell Win Pharmaceuticals Private Limited?

The primary industry of Dell Win Pharmaceuticals Private Limited is Trade.

Is Dell Win Pharmaceuticals Private Limited a listed company?

Dell Win Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dell Win Pharmaceuticals Private Limited?

The authorized capital of Dell Win Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available